Approval · Notice of Compliance 5064 · 1995
ROFERON-A: Notice of Compliance 5064
Issued July 7, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5064
- Date
- July 7, 1995
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROFERON-A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALPHA-2A 3,000,000 UNIT per VIAL
- INTERFERON ALPHA-2A 4,500,000 UNIT per VIAL
- INTERFERON ALPHA-2A 9,000,000 UNIT per VIAL
- INTERFERON ALPHA-2A 18,000,000 UNIT per VIAL